Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Relugolix in combination with estradiol/norethindrone acetate for moderate to severe symtpoms of uterine fibroids Relugolix (TAK-385) Heavy menstrual bleeding Gynaecology and Obstetrics 2020 View  |  Download
Relugolix for treating advanced hormone-sensitive prostate cancer Relugolix (TAK-385) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
Relugolix combination therapy for treating endometriosis-associated pain Relugolix (TAK-385) Endometriosis-associated pain Gynaecology and Obstetrics , Pain Relief 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications